Published :
Tables : 49
Figures : 44
Category : Healthcare
No. of Pages : 226
Report Code : HC-1157
Inflation Device Market is poised to value USD 721.00 million by 2028 end at a CAGR of 4.7% during the forecast period 2022 to 2028. With an increase in the incidence of target diseases, given the high risk and exposure to chronic diseases due to an unhealthy sedentary lifestyle and rising geriatric population, all these factors accelerate, promote and positively push the global market. Furthermore, adding to these factors, beneficial medical reimbursement for minimally invasive procedures in developed countries, advancing demand for minimally invasive surgical procedures across global powers, and increasing applications of inflation devices are the principal determinants driving the growth of the inflation devices market. Government initiatives to control the burden of healthcare-associated infections in developed countries and escalating healthcare expenditure across emerging markets are further assisting market growth. In terms of market segmentation, in terms of the capacity segment, the global market is differentiated into 20ml, 30ml, and 60ml inflation devices. The 60ml inflation devices segment is anticipated to flourish at the most active CAGR during the forecast period. These devices have easy accessibility and mechanisms and are intended to be handy, which has promoted their application in various industries. Implementation of these devices in pulmonary, gastroenterology, and otolaryngology procedures is growing increasingly popular, as these techniques utilize comparatively larger-sized balloons and requires more liquid for inflation. According to the application, the market is characterized by interventional cardiology, interventional radiology, peripheral vascular procedures, urological procedures, gastroenterological procedures, and other applications. Among these, the interventional cardiology segment valued for the most substantial share of the inflation device market. The mounting ageing population is more predisposed to develop CVD, which is a significant circumstance driving the adoption of interventional cardiology procedures that utilizes inflation devices. Furthermore, mushrooming in the quantity of new multi-specialty hospitals in developing countries offering advanced minimally invasive procedures, promising reimbursement scenario for angioplasty procedures will additionally stimulate the growth of the division over the forecast period. In terms of end-user, the hospitals and clinics segment is the largest contributor to the inflation devices market due to the expanding amount of hospitals and specialty clinics in developing nations, the growing predominance of target diseases; and a considerable number of surgical and diagnostic procedures implemented across these amenities. Asia Pacific is anticipated to advance at the highest CAGR in the market during the forecast period. North America is foreseen to value for the most considerable share in the global market. Business germination is motivated by the increasing frequency of minimally invasive surgical procedures, advancing healthcare infrastructure, rising awareness about HAIs and the use of disposable devices, and the increasing adoption of minimally invasive procedures. Major market companies operating globally are: Merit Medical Systems, Boston Scientific Corporation, Cardinal Health, CONMED Corporation, Medtronic plc, Acclarent Inc., Cook Medical, Atrion Corporation, Becton, Dickinson and Company, Terumo Medical Corporation, B. Braun Melsungen AG, Olympus Corporation, Teleflex Incorporated, and US Endovascular. Major market firms are undertaking strategic initiatives to increase their presence in emerging countries to leverage the growth opportunities in these markets will further contribute to the market growth. Market Segmentation By Capacity 20ml Inflation Devices 30ml Inflation Devices 60ml Inflation Devices By Display Type Analog Inflation Devices Digital Inflation Devices By Application Interventional Cardiology Interventional Radiology Peripheral Vascular Procedures Gastroenterological Procedures Urological Procedures Other Applications By End User Hospitals and Clinics Ambulatory Surgery Centers By Region: Europe North America APAC Latin America Middle East and Africa Inflation Device Market Sample Video: Competitive Landscape: ● Tier 1 players- established companies in the market with a major market share ● Tier 2 players ● Emerging players which are growing rapidly ● New Entrants FutureWise Takeaways ● Growth prospects ● SWOT analysis ● Key trends ● Key data points affecting market growth Objectives of the Study: ● To provide an exhaustive analysis on the global market by capacity, by display type, by application, by end-user, and by region ● To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) ● To evaluate and forecast micro-markets and the overall market ● To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa ● To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions ● Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
With an increase in the incidence of target diseases, given the high risk and exposure to chronic diseases due to an unhealthy sedentary lifestyle and rising geriatric population, all these factors accelerate, promote and positively push the global market. Furthermore, adding to these factors, beneficial medical reimbursement for minimally invasive procedures in developed countries, advancing demand for minimally invasive surgical procedures across global powers, and increasing applications of inflation devices are the principal determinants driving the growth of the inflation devices market. Government initiatives to control the burden of healthcare-associated infections in developed countries and escalating healthcare expenditure across emerging markets are further assisting market growth.
In terms of market segmentation, in terms of the capacity segment, the global market is differentiated into 20ml, 30ml, and 60ml inflation devices. The 60ml inflation devices segment is anticipated to flourish at the most active CAGR during the forecast period. These devices have easy accessibility and mechanisms and are intended to be handy, which has promoted their application in various industries. Implementation of these devices in pulmonary, gastroenterology, and otolaryngology procedures is growing increasingly popular, as these techniques utilize comparatively larger-sized balloons and requires more liquid for inflation.
According to the application, the market is characterized by interventional cardiology, interventional radiology, peripheral vascular procedures, urological procedures, gastroenterological procedures, and other applications. Among these, the interventional cardiology segment valued for the most substantial share of the inflation device market. The mounting ageing population is more predisposed to develop CVD, which is a significant circumstance driving the adoption of interventional cardiology procedures that utilizes inflation devices. Furthermore, mushrooming in the quantity of new multi-specialty hospitals in developing countries offering advanced minimally invasive procedures, promising reimbursement scenario for angioplasty procedures will additionally stimulate the growth of the division over the forecast period.
In terms of end-user, the hospitals and clinics segment is the largest contributor to the inflation devices market due to the expanding amount of hospitals and specialty clinics in developing nations, the growing predominance of target diseases; and a considerable number of surgical and diagnostic procedures implemented across these amenities.
Asia Pacific is anticipated to advance at the highest CAGR in the market during the forecast period. North America is foreseen to value for the most considerable share in the global market. Business germination is motivated by the increasing frequency of minimally invasive surgical procedures, advancing healthcare infrastructure, rising awareness about HAIs and the use of disposable devices, and the increasing adoption of minimally invasive procedures.
Major market companies operating globally are:
Merit Medical Systems, Boston Scientific Corporation, Cardinal Health, CONMED Corporation, Medtronic plc, Acclarent Inc., Cook Medical, Atrion Corporation, Becton, Dickinson and Company, Terumo Medical Corporation, B. Braun Melsungen AG, Olympus Corporation, Teleflex Incorporated, and US Endovascular.
Major market firms are undertaking strategic initiatives to increase their presence in emerging countries to leverage the growth opportunities in these markets will further contribute to the market growth.
Market Segmentation
By Capacity
By Display Type
By Application
By End User
By Region:
Inflation Device Market Sample Video:
Competitive Landscape:
● Tier 1 players- established companies in the market with a major market share
● Tier 2 players
● Emerging players which are growing rapidly
● New Entrants
FutureWise Takeaways
● Growth prospects
● SWOT analysis
● Key trends
● Key data points affecting market growth
Objectives of the Study:
● To provide an exhaustive analysis on the global market by capacity, by display type, by application, by end-user, and by region
● To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
● To evaluate and forecast micro-markets and the overall market
● To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
● To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
● Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Inflation Device Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Inflation Device Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Inflation Device Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Inflation Device Market, By Capacity Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. 20ml Inflation Devices 7.2. 30ml Inflation Devices 7.3. 60ml Inflation Devices 8. Inflation Device Market, By Display Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Analog Inflation Devices 8.2. Digital Inflation Devices 9. Inflation Device Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Interventional Cardiology 9.2. Interventional Radiology 9.3. Peripheral Vascular Procedures 9.4. Gastroenterological Procedures 9.5. Urological Procedures 9.6. Other Applications 10. Inflation Device Market, By End-User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Hospitals and Clinics 10.2. Ambulatory Surgery Centers 11. North America Inflation Device Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028 12. Latin America Inflation Device Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028 13. Europe Inflation Device Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028 14. Asia Pacific Inflation Device Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028 16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Merit Medical Systems 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Boston Scientific Corporation 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Cardinal Health 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. CONMED Corporation 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Medtronic plc 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Acclarent Inc. 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Cook Medical 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Atrion Corporation 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Becton, Dickinson and Company 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Terumo Medical Corporation 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11.B. Braun Melsungen AG 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12.Olympus Corporation 17.10.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 17.13.Teleflex Incorporated 17.13.1. Company Overview 17.13.2. Product Portfolio 17.13.3. SWOT Analysis 17.13.4. Financial Overview 17.13.5. Strategic Overview 17.14.US Endovascular 17.14.1. Company Overview 17.14.2. Product Portfolio 17.14.3. SWOT Analysis 17.14.4. Financial Overview 17.14.5. Strategic Overview 18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Inflation Device Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Inflation Device Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Inflation Device Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Inflation Device Market, By Capacity Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. 20ml Inflation Devices 7.2. 30ml Inflation Devices 7.3. 60ml Inflation Devices
8. Inflation Device Market, By Display Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Analog Inflation Devices 8.2. Digital Inflation Devices
9. Inflation Device Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Interventional Cardiology 9.2. Interventional Radiology 9.3. Peripheral Vascular Procedures 9.4. Gastroenterological Procedures 9.5. Urological Procedures 9.6. Other Applications
10. Inflation Device Market, By End-User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Hospitals and Clinics 10.2. Ambulatory Surgery Centers
11. North America Inflation Device Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028
12. Latin America Inflation Device Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028
13. Europe Inflation Device Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028
14. Asia Pacific Inflation Device Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028
16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Merit Medical Systems 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Boston Scientific Corporation 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Cardinal Health 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. CONMED Corporation 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Medtronic plc 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Acclarent Inc. 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Cook Medical 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Atrion Corporation 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Becton, Dickinson and Company 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Terumo Medical Corporation 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11.B. Braun Melsungen AG 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12.Olympus Corporation 17.10.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 17.13.Teleflex Incorporated 17.13.1. Company Overview 17.13.2. Product Portfolio 17.13.3. SWOT Analysis 17.13.4. Financial Overview 17.13.5. Strategic Overview 17.14.US Endovascular 17.14.1. Company Overview 17.14.2. Product Portfolio 17.14.3. SWOT Analysis 17.14.4. Financial Overview 17.14.5. Strategic Overview
18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics